Advertisement

Topics

IRL BioPharm Ltd Company Profile

19:20 EDT 24th September 2018 | BioPortfolio

Our specialty is microbial fermentation of novel, potent secondary metabolites with extensive experience in producing cytotoxins for antibody drug conjugates. We partner companies for process development and manufacture to support pre-clinical through to phase 3 trials under cGMP conditions. IRL BioPharm is skilled in maximising yield and mitigating risk during process development to ensure that scale-up and commercial technology transfer occurs smoothly.

Location

Box 31-310
Lower Hutt
New Zealand

Contact

Phone: 64 4 9313000
Email: info@irlbiopharm.com


News Articles [78 Associated News Articles listed on BioPortfolio]

Win a FREE TICKET to BioPharm America 2018

If you haven’t heard of BioPharm America™, here’s what you need to know: BioPharm America is an international partnering conference with a focus on the life science industry. The conferen...

Janssen to acquire BeneVir Biopharm for up to $1bn

Johnson & Johnson subsidiary Janssen Biotech has signed a definitive agreement to buy biotechnology company BeneVir Biopharm for a total...Read More... The post Janssen to acquire BeneVir Biopharm...

Johnson & Johnson Acquire BeneVir Biopharm

NewsJanssen will gain Benevir Biopharm's oncolytic immunotherapy platform in the acquisition.

Tot Biopharm launches mAb manufacturing plant in China

Tot Biopharm has opened its second monoclonal antibody (mAb) production plant in Suzhou Industrial Park, China.

#jobs #lifescience BioPharm/BioTech

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: BioPharm/BioTech .MA-Cambridge, BioPharma/BioTech BIOPHARMA/BIOTECH Amgen, In...

TC BioPharm, Scotia Biologics partner for cancer drug R&D

Biotechnology company TC BioPharm and Scotia Biologics agreed to work together to develop therapies for cancer and major vira -More- 

J&J Janssen arm to Buy Benevir Biopharm

BeneVir Biopharm, a privately-held biotechnology company in the life science portfolio of the HC2 holding, will be bought by Janssen Biotech, a subsidiary of Johnson & Johnson under a recently sig...

Janssen Biotech to buy BeneVir Biopharm in $1bn deal

Janssen Biotech has agreed to acquire US-based BeneVir Biopharm, a biopharmaceutical company focused on developing oncolytic immunotherapies for cancer, in a deal worth $1.04bn.

Drugs and Medications [0 Results]

None

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Corrigendum to "An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers" Eur. J. Pharm. Biopharm. 127 (2018) 432-442.

\TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis.

Tumor-specific neoantigens have attracted much attention since they can be used as biomarkers to predict therapeutic effects of immune checkpoint blockade therapy and as potential targets for cancer i...

Staphylococcus aureus colonization and risk of surgical site infection in children undergoing clean elective surgery: A cohort study.

Staphylococcus aureus persistently colonizes the skin and nasopharynx of approximately 20% to 30% of individuals, with the highest rates in younger children. To avoid clinical problems for carriers an...

Curcumin loaded selenium nanoparticles synergize the anticancer potential of doxorubicin contained in self-assembled, cell receptor targeted nanoparticles.

Doxorubicin (DOX) has been extensively used to treat a wide range of cancers in free and nanotized form. Nanotization of Doxorubicin (DOX) has alleviated its toxicity and efflux-mediated resistance. H...

Clinical Trials [0 Results]

None

Companies [33 Associated Companies listed on BioPortfolio]

BioPharm Services US

BioPharm Services was first registered in 1998 and now employs more than 10 people in 2 offices in the US and UK. The company provides a broad spectrum of consultancy services covering all aspects of ...

R-Biopharm Inc.

R-Biopharm AG was founded in 1988 as a subsidiary of the company Röhm AG in Darmstadt. In 1991 R-Biopharm was acquired by Dr. Ralf Dreher through a management buy out. The main activity is the develo...

TTY Biopharm

TTY Biopharm stands to innovate the industry,emerge anew from the ashes of self-kindled flames, and accept multi challenges, encourage enterprising ventures, and share its knowledge and information.

Biopharm

Biopharm is a multinational company founded in 1995 by a group of scientists and business executives with the vision of developing innovative natural nutraceuticals that are backed by solid scientific...

BioPharm Insight

BioPharm Insight is the most comprehensive life science market intelligence and analytics solution, featuring a team of investigative journalists writing exclusive news and thousa...

More Information about "IRL BioPharm Ltd" on BioPortfolio

We have published hundreds of IRL BioPharm Ltd news stories on BioPortfolio along with dozens of IRL BioPharm Ltd Clinical Trials and PubMed Articles about IRL BioPharm Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IRL BioPharm Ltd Companies in our database. You can also find out about relevant IRL BioPharm Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record